Vaxil Cash Per Share vs Roe Analysis
VXL Stock | CAD 0.01 0.00 0.00% |
Vaxil Bio financial indicator trend analysis is much more than just breaking down Vaxil Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxil Bio is a good investment. Please check the relationship between Vaxil Bio Cash Per Share and its Roe accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Cash Per Share vs Roe
Cash Per Share vs Roe Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxil Bio Cash Per Share account and Roe. At this time, the significance of the direction appears to have no relationship.
The correlation between Vaxil Bio's Cash Per Share and Roe is 0.07. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Roe in the same time period over historical financial statements of Vaxil Bio, assuming nothing else is changed. The correlation between historical values of Vaxil Bio's Cash Per Share and Roe is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Vaxil Bio are associated (or correlated) with its Roe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Roe has no effect on the direction of Cash Per Share i.e., Vaxil Bio's Cash Per Share and Roe go up and down completely randomly.
Correlation Coefficient | 0.07 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Cash Per Share
Roe
Most indicators from Vaxil Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxil Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to drop to 114.00 in 2024. Enterprise Value Over EBITDA is likely to climb to -9.3 in 2024
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 986K | 584K | 254.0 | 241.3 | Cost Of Revenue | 25K | 2K | 1.8K | 1.7K |
Vaxil Bio fundamental ratios Correlations
Click cells to compare fundamentals
Vaxil Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxil Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 205K | 1.7M | 2.3M | 1.5M | 976K | 853.8K | |
Other Current Liab | 63K | 260K | 584.4K | 404.6K | 84.9K | 80.7K | |
Total Current Liabilities | 777K | 857K | 585K | 405K | 85K | 80.8K | |
Total Stockholder Equity | (583K) | 804K | 1.7M | 1.1M | 891K | 446.7K | |
Property Plant And Equipment Net | 118K | 62K | 95K | 27K | 2K | 0.0 | |
Net Debt | (66K) | (1.5M) | (2.2M) | (1.5M) | (938K) | (984.9K) | |
Retained Earnings | (16.2M) | (17.5M) | (18.5M) | (19.1M) | (19.4M) | (18.4M) | |
Accounts Payable | 618K | 588K | 559.0 | 394.0 | 85.0 | 80.75 | |
Cash | 753K | 83K | 1.5M | 2.2M | 938K | 665.5K | |
Non Current Assets Total | 118K | 62K | 95K | 27K | 2K | 0.0 | |
Cash And Short Term Investments | 753K | 83K | 1.5M | 2.2M | 938K | 665.5K | |
Net Receivables | 11K | 33K | 35K | 20K | 19K | 21.4K | |
Common Stock Shares Outstanding | 88.9M | 101.7M | 136.1M | 137.0M | 137.0M | 143.8M | |
Liabilities And Stockholders Equity | 205K | 1.7M | 2.3M | 1.5M | 976K | 853.8K | |
Other Current Assets | 16K | 91K | 7K | 11K | 38.0 | 36.1 | |
Other Stockholder Equity | 1.9M | 816K | 755K | 358K | 324K | 0.0 | |
Total Liab | 788K | 857K | 585K | 405K | 85K | 80.8K | |
Total Current Assets | 110K | 1.6M | 2.3M | 1.5M | 976K | 723.9K | |
Accumulated Other Comprehensive Income | 3.6M | 3.7M | 3.8M | 3.8M | 4.2M | 2.3M | |
Net Tangible Assets | 435K | (583K) | 804K | 1.7M | 2.0M | 2.1M | |
Short Term Debt | 29K | 5K | 6K | 9K | 8.1K | 8.8K | |
Property Plant Equipment | 62K | 95K | 27K | 2K | 1.8K | 1.7K | |
Net Invested Capital | (583K) | 804K | 1.7M | 1.1M | 891K | 612.2K | |
Net Working Capital | (667K) | 777K | 1.7M | 1.1M | 891K | 573.9K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.